Correlation Between Enliven Therapeutics and Oruka Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Oruka Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Oruka Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Oruka Therapeutics,, you can compare the effects of market volatilities on Enliven Therapeutics and Oruka Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Oruka Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Oruka Therapeutics,.
Diversification Opportunities for Enliven Therapeutics and Oruka Therapeutics,
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Enliven and Oruka is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Oruka Therapeutics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oruka Therapeutics, and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Oruka Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oruka Therapeutics, has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Oruka Therapeutics, go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Oruka Therapeutics,
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.54 times more return on investment than Oruka Therapeutics,. However, Enliven Therapeutics is 1.86 times less risky than Oruka Therapeutics,. It trades about 0.07 of its potential returns per unit of risk. Oruka Therapeutics, is currently generating about -0.02 per unit of risk. If you would invest 2,220 in Enliven Therapeutics on September 2, 2024 and sell it today you would earn a total of 218.00 from holding Enliven Therapeutics or generate 9.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Oruka Therapeutics,
Performance |
| Timeline |
| Enliven Therapeutics |
| Oruka Therapeutics, |
Enliven Therapeutics and Oruka Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Oruka Therapeutics,
The main advantage of trading using opposite Enliven Therapeutics and Oruka Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Oruka Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oruka Therapeutics, will offset losses from the drop in Oruka Therapeutics,'s long position.| Enliven Therapeutics vs. Crinetics Pharmaceuticals | Enliven Therapeutics vs. Enanta Pharmaceuticals | Enliven Therapeutics vs. Amicus Therapeutics | Enliven Therapeutics vs. Connect Biopharma Holdings |
| Oruka Therapeutics, vs. Tff Pharmaceuticals | Oruka Therapeutics, vs. Eliem Therapeutics | Oruka Therapeutics, vs. Inhibrx | Oruka Therapeutics, vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |